Diabetes drug may reduce brain damage after stroke (EurekAlert, 3 December 2012)

04 Dec 2012


A study from Sweden published in Diabetes assesses the neuroprotective potential of the DPP-4 inhibitor linagliptin in a mouse model of stroke in both normal and diabetic mice.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story